Clinical trial

Extension Study of Participants From SPG302-ALZ-101

NCT06833281

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2025-03-25

PhasePHASE2

Study timeline

Study start (actual)2025-03-25Date precision: day

Registry last updated2025-12-18

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Alzheimer's Diseaseunresolved

Interventions

SPG302DRUG

Sponsors & collaborators

Spinogenixlead sponsor

Mapped research locations

AdelaideSouth Australia, Australia1 SydneyNew South Wales, Australia1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06833281 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.